Xenetic Biosciences (XBIO) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,704.59+0.94%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Xenetic Biosciences Inc (XBIO) Stock Price, Quote, News & History

XBIONASDAQ

Trade with Public

Trade with Public

$2.19

0.073.3%

Last update: Oct 9, 3:59 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

-

Close

$2.19

Volume / Avg.

10.18K / 85.80K

Day Range

$2.13 - $2.13

52 Wk Range

1.87 - 13.93

Market Cap

$4.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

36

Short Interest

0.57%

Days to Cover

1

Recent Xenetic Biosciences Inc News

Crude Oil Down Over 3%; US Business Inventories Surge In July

U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.

Avi Kapoor

Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition

Xenetic Biosciences plans to acquire Santersus in an all-stock deal, forming Santersus Bio to tackle NET-driven diseases.

Vandana Singh

Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates

U.S. stocks edged higher as strong retail sales lifted sentiment; utilities gained, energy fell, oil dropped, while European and Asian markets advanced.

Avi Kapoor

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges

Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.

Henry Khederian

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs. Here's a look at four stocks flashing strong momentum signals.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.31M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

-

Free Cash Flow (TTM)

-2.31M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

1.69M

Valuation Metrics

Enterprise Value

-$1.48M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.35

PB Ratio (TTM)

0.82

Earnings Yield % (TTM)

-54.25%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.59

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$6.47M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-